Table 3.
Characteristics of chronic hepatitis B (CHB) with nonalcoholic fatty liver disease (NAFLD) for the non-fibrosis and fibrosis groups.
| Characteristic | CHB with NAFLD |
||
|---|---|---|---|
| Non-fibrosis group | Fibrosis group | p Value | |
| Sample size, n | 92 | 57 | |
| Sex (male), n (%) | 68 (73.9) | 49 (86.0) | 0.082 |
| Age (years) | 40.00 ± 11.79 | 41.19 ± 13.06 | 0.566 |
| Smoking, n (%) | 25 (27.2) | 18 (31.6) | 0.564 |
| Alcohol consumption, n (%) | 30 (32.6) | 21 (36.8) | 0.597 |
| T2DM, n (%) | 10 (10.9) | 11 (19.3) | 0.151 |
| Metabolic syndrome, n (%) | 16 (17.4) | 14 (24.6) | 0.289 |
| Weight, kg | 77.44 ± 17.25 | 84.64 ± 16.27 | 0.013 |
| Height, cm | 167.69 ± 7.75 | 169.02 ± 6.59 | 0.286 |
| SBP, mm Hg | 131.59 ± 12.31 | 133.32 ± 14.66 | 0.443 |
| DBP, mm Hg | 85.49 ± 8.73 | 86.56 ± 11.45 | 0.523 |
| Waist circumference, cm | 90.08 ± 7.32 | 95.81 ± 9.68 | <0.001 |
| Hip circumference, cm | 96.64 ± 6.58 | 99.92 ± 7.78 | 0.007 |
| CAP, dB/m | 334.26 ± 16.66 | 336.40 ± 21.53 | 0.499 |
| PLT, 109/l | 253.51 ± 56.69 | 233.19 ± 69.49 | 0.056 |
| ALT, U/l | 87.96 ± 51.41 | 87.72 ± 24.41 | 0.973 |
| AST, U/l | 53.13 ± 16.53 | 73.23 ± 20.83 | <0.001 |
| GGT, U/l | 76.27 ± 39.66 | 67.42 ± 28.99 | 0.156 |
| Total cholesterol, mmol/l | 5.29 ± 0.58 | 5.08 ± 0.92 | 0.115 |
| HDL-cholesterol, mmol/l | 1.29 ± 0.30 | 1.34 ± 0.29 | 0.327 |
| LDL-cholesterol, mmol/l | 3.31 ± 0.54 | 2.98 ± 0.79 | 0.015 |
| Triglycerides, mmol/l | 1.61 ± 0.56 | 1.49 ± 0.45 | 0.180 |
| Uric acid, mmol/l | 405.11 ± 75.46 | 547.35 ± 135.06 | <0.001 |
| HBV DNA, log10 IU/ml | 0.95 ± 1.84 | 1.03 ± 1.51 | 0.769 |
| HBeAg ( + ), n (%) | 49 (53.3) | 41 (71.9) | 0.024 |
ALT: serum aspartate aminotransferase; AST: alanine aminotransferase; CAP: controlled attenuation parameter; DBP: diastolic blood pressure; GGT: gamma-glutamyltransferase; HBeAg: hepatitis B e antigen; HBV: hepatitis B virus; HDL: high density lipoprotein; LDL: low density lipoprotein; PLT: platelet; SBP: systolic blood pressure; T2DM: type 2 diabetes mellitus.